Search

Your search keyword '"Ruparelia, A. A."' showing total 84 results

Search Constraints

Start Over You searched for: Author "Ruparelia, A. A." Remove constraint Author: "Ruparelia, A. A." Publisher wiley Remove constraint Publisher: wiley
84 results on '"Ruparelia, A. A."'

Search Results

1. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease

2. Featured Cover

3. Iris-Occlusion of XEN Gel Stent following Ab Externo Transconjunctival Implantation Technique

4. The African killifish: A short‐lived vertebrate model to study the biology of sarcopenia and longevity

6. The characterization of Pluronic <scp>P123</scp> micelles in the presence of sunscreen agents

9. Enhancing employability opportunities for Pharmacy students; a case study of processes to implement competency‐based education in Pharmacy in Kenya

11. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's disease.

12. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild-to-moderate Alzheimer's disease

13. Safety of hospital discharge before return of bowel function after elective colorectal surgery

14. A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease

15. A comparison of the fully repositionable and retrievable <scp>B</scp> oston <scp>L</scp> otus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience

17. Initial experience of a large, self‐expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters’ registry

18. Percutaneous left atrial appendage occlusion with the Amulet device: The impact of device disc position upon periprocedural and long-term outcomes

22. Solvent degradation studies using hydrodynamic cavitation

23. Stem cells in skeletal muscle growth and regeneration in amniotes and teleosts: Emerging themes

26. Facilitating right‐sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations

27. Flavones as tyrosinase inhibitors: kinetic studies in vitro and in silico

28. Technical considerations facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and Ultra valves

29. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels

30. Left atrial appendage closure: A single center experience and comparison of two contemporary devices

31. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound

32. Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry

33. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry

34. Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure

35. Initial findings using the V8 hourglass-shaped valvuloplasty balloon for postdilatation in treating paravalvular leaks associated with transcatheter self-expanding aortic valve prosthesis

37. Facilitating right‐sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations

39. Planned versus provisional rotational atherectomy for severe calcified coronary lesions: Insights From the ROTATE multi-center registry

40. Modified contrast microinjection technique to facilitate chronic total occlusion recanalization

41. Clinical outcomes following target lesion revascularization for bioresorbable scaffold failure

42. Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade

43. Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy

44. Genetic variants in or nearADH1BandADH1Caffect susceptibility to alcohol dependence in a British and Irish population

45. Initial experience of a large, self‐expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters’ registry

46. Percutaneous left atrial appendage occlusion with the Amulet device: The impact of device disc position upon periprocedural and long-term outcomes

47. Aging and intellectual disability: Insights from mouse models of down syndrome

48. Tangeretin and its metabolite 4′-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K

49. Measuring whole-body neutrophil redistribution using a dedicated whole-body counter and ultra-low doses of 111Indium

Catalog

Books, media, physical & digital resources